Open access publisher BioMed Central, US, has announced that the Journal of Experimental & Clinical Cancer Research (JECCR) has moved to BioMed Central's open access publishing platform. Overseen by Editor-in-Chief Mauro Castelli and supported by an international Editorial Board, the journal has joined BioMed Central in order to provide rapid dissemination of scientific results to the widest possible global audience.
The official journal of the "Regina Elena" National Cancer Institute, JECCR seeks to provide a forum for basic, clinical and translational work in oncology. The journal publishes scientific studies on the immunological, epidemiological, pathological, biological and clinical aspects of oncology. Topics considered range from molecular genetics via infectious agents to surgery and therapeutic approaches and outcomes.
JECCR is tracked/indexed by Thomson Reuters, Medline, Embase and CAS.
